肠道微生物失衡与腹膜透析：关联探索与临床启示
Gut Microbiota Imbalance and Peritoneal Dialysis: Exploration of the Association and Clinical Implications
DOI: 10.12677/acm.2025.1541202, PDF,    科研立项经费支持
作者: 徐佳宁, 吴少锐：绍兴文理学院医学院，浙江 绍兴；沈水娟, 杨燕茹, 吴秀娟*：绍兴文理学院附属第一医院，绍兴市人民医院肾内科，浙江 绍兴
关键词: 肠道微生物；腹膜透析；腹膜透析腹膜炎；技术失败；营养状态；Gut Microbiota； Peritoneal Dialysis； Peritoneal Dialysis-Associated Peritonitis； Technical Failure； Nutritional Status
摘要: 肠道微生物改变与慢性肾脏病的关系密切，尤其是终末期肾脏病腹膜透析患者。本文探讨了肠道微生物群落的组成和功能变化与腹膜透析患者的关系，包括对腹膜透析腹膜炎、炎症反应、技术失败、营养状态等方面的影响。同时，也介绍了调节肠道微生物以改善腹膜透析患者预后的潜在策略。
Abstract: Alterations in gut microbiota are closely related to chronic kidney disease, especially in patients with end-stage renal disease undergoing peritoneal dialysis. This article explores the relationship between the composition and functional changes of gut microbial communities and patients undergoing peritoneal dialysis, including their impact on peritoneal dialysis-associated peritonitis, inflammatory responses, technical failure, nutritional status, and other aspects. Additionally, it introduces potential strategies for modulating gut microbiota to improve the prognosis of peritoneal dialysis patients.
文章引用：徐佳宁, 沈水娟, 杨燕茹, 吴少锐, 吴秀娟. 肠道微生物失衡与腹膜透析：关联探索与临床启示[J]. 临床医学进展, 2025, 15(4): 2470-2475. https://doi.org/10.12677/acm.2025.1541202

参考文献

[1] 罗丹, 张俊, 赵文波, 等. 血液透析和腹膜透析对终末期肾脏病患者肠道菌群的影响[J]. 新医学, 2019, 50(6): 419-426.
[2] Sampaio-Maia, B., Simões-Silva, L., Pestana, M., Araujo, R. and Soares-Silva, I.J. (2016) The Role of the Gut Microbiome on Chronic Kidney Disease. In: Advances in Applied Microbiology, Elsevier, 65-94. [Google Scholar] [CrossRef] [PubMed]
[3] Vaziri, N.D., Wong, J., Pahl, M., Piceno, Y.M., Yuan, J., DeSantis, T.Z., et al. (2013) Chronic Kidney Disease Alters Intestinal Microbial Flora. Kidney International, 83, 308-315. [Google Scholar] [CrossRef] [PubMed]
[4] Wang, Y., Al-Dakkak, I., Garlo, K., Ong, M., Tomazos, I. and Mahajerin, A. (2023) Atypical Hemolytic Uremic Syndrome Treated with Ravulizumab or Eculizumab: A Claims-Based Evaluation of Health Care Resource Utilization and Clinical Outcomes in the United States. Kidney Medicine, 5, Article ID: 100683. [Google Scholar] [CrossRef] [PubMed]
[5] Simões-Silva, L., Araujo, R., Pestana, M., Soares-Silva, I. and Sampaio-Maia, B. (2020) Peritoneal Microbiome in End-Stage Renal Disease Patients and the Impact of Peritoneal Dialysis Therapy. Microorganisms, 8, Article No. 173. [Google Scholar] [CrossRef] [PubMed]
[6] 白家兰, 杨聚荣, 吴科熠. 肠道微生态与终末期肾病患者腹膜透析相关性腹膜炎发生的关系[J]. 热带医学杂志, 2023, 23(2): 222-225+240+286
[7] Wang, I., Lai, H., Yu, C., Liang, C., Chang, C., Kuo, H., et al. (2012) Real-Time PCR Analysis of the Intestinal Microbiotas in Peritoneal Dialysis Patients. Applied and Environmental Microbiology, 78, 1107-1112. [Google Scholar] [CrossRef] [PubMed]
[8] Simões-Silva, L., Araujo, R., Pestana, M., Soares-Silva, I. and Sampaio-Maia, B. (2018) The Microbiome in Chronic Kidney Disease Patients Undergoing Hemodialysis and Peritoneal Dialysis. Pharmacological Research, 130, 143-151. [Google Scholar] [CrossRef] [PubMed]
[9] Szeto, C., Chow, K., Yuk-Hwa Wong, T., Leung, C. and Kam-Tao Li, P. (2002) Conservative Management of Polymicrobial Peritonitis Complicating Peritoneal Dialysis—A Series of 140 Consecutive Cases. The American Journal of Medicine, 113, 728-733. [Google Scholar] [CrossRef] [PubMed]
[10] Barraclough, K., Hawley, C.M., McDonald, S.P., Brown, F.G., Rosman, J.B., Wiggins, K.J., et al. (2010) Polymicrobial Peritonitis in Peritoneal Dialysis Patients in Australia: Predictors, Treatment, and Outcomes. American Journal of Kidney Diseases, 55, 121-131. [Google Scholar] [CrossRef] [PubMed]
[11] Edey, M., Hawley, C.M., McDonald, S.P., Brown, F.G., Rosman, J.B., Wiggins, K.J., et al. (2009) Enterococcal Peritonitis in Australian Peritoneal Dialysis Patients: Predictors, Treatment and Outcomes in 116 Cases. Nephrology Dialysis Transplantation, 25, 1272-1278. [Google Scholar] [CrossRef] [PubMed]
[12] Zhou, J., Yang, C., Lei, W., Yang, Z., Chen, J. and Lin, H. (2022) Exploration of the Correlation between Intestinal Flora and Peritoneal Dialysis-Related Peritonitis. Clinical and Experimental Nephrology, 26, 1030-1038. [Google Scholar] [CrossRef] [PubMed]
[13] 何阶德, 黄朦, 黄存军, 等. 腹膜透析相关性腹膜炎患者肠道菌群变化研究[J]. 检验医学与临床, 2024, 21(7): 923-928.
[14] Cani, P.D., Depommier, C., Derrien, M., Everard, A. and de Vos, W.M. (2022) Akkermansia muciniphila: Paradigm for Next-Generation Beneficial Microorganisms. Nature Reviews Gastroenterology & Hepatology, 19, 625-637. [Google Scholar] [CrossRef] [PubMed]
[15] Cheng, T., Li, C., Shen, L., Wang, S., Li, X., Fu, C., et al. (2022) The Intestinal Effect of Atorvastatin: Akkermansia muciniphila and Barrier Function. Frontiers in Microbiology, 12, Article ID: 797062. [Google Scholar] [CrossRef] [PubMed]
[16] Khan, S. and Jena, G. (2014) Sodium Butyrate, a HDAC Inhibitor Ameliorates Enos, Inos and TGF-Β1-Induced Fibrogenesis, Apoptosis and DNA Damage in the Kidney of Juvenile Diabetic Rats. Food and Chemical Toxicology, 73, 127-139. [Google Scholar] [CrossRef] [PubMed]
[17] McNabney, S. and Henagan, T. (2017) Short Chain Fatty Acids in the Colon and Peripheral Tissues: A Focus on Butyrate, Colon Cancer, Obesity and Insulin Resistance. Nutrients, 9, Article No. 1348. [Google Scholar] [CrossRef] [PubMed]
[18] Chen, K., Yang, J., Xiao, F., Chen, J., Hu, W., Wang, X., et al. (2020) Early Peritoneal Dialysis Ameliorates Blast Lung Injury by Alleviating Pulmonary Edema and Inflammation. Shock, 53, 95-102. [Google Scholar] [CrossRef] [PubMed]
[19] Boonyarittipong, M., Kurathong, S. and Trakarnvanich, T. (2019) Interleukin-6, Procalcitonin, and Vascular Endothelial Growth Factor in Plasma and Dialysate Correlate with Dialysis Adequacy in Continuous Ambulatory Peritoneal Dialysis Patients. Clinical Nephrology, 92, 273-276. [Google Scholar] [CrossRef] [PubMed]
[20] 丁嘉祥, 甘红兵, 杨清华, 等. 腹膜透析贫血合并炎症状态的诊治1例报告[J]. 中国实用内科杂志, 2020, 40(11): 964-965.
[21] Ding, L., Zhao, X., Zhu, N., Zhao, M., Hu, Q. and Ni, Y. (2020) The Balance of Serum IL-18/IL-37 Levels Is Disrupted during the Development of Oral Squamous Cell Carcinoma. Surgical Oncology, 32, 99-107. [Google Scholar] [CrossRef] [PubMed]
[22] 李玉霞, 赵子娜, 李江花, 等. 肠道菌群失衡与腹膜透析患者血清炎性因子的相关性及对患者预后的影响[J]. 中国微生态学杂志, 2022, 34(9): 1066-1070.
[23] Zhang, L., Xie, F., Tang, H., Zhang, X., Hu, J., Zhong, X., et al. (2022) Gut Microbial Metabolite TMAO Increases Peritoneal Inflammation and Peritonitis Risk in Peritoneal Dialysis Patients. Translational Research, 240, 50-63. [Google Scholar] [CrossRef] [PubMed]
[24] Smits, L.P., Kootte, R.S., Levin, E., Prodan, A., Fuentes, S., Zoetendal, E.G., et al. (2018) Effect of Vegan Fecal Microbiota Transplantation on Carnitine‐ and Choline‐Derived Trimethylamine‐n‐Oxide Production and Vascular Inflammation in Patients with Metabolic Syndrome. Journal of the American Heart Association, 7, e008342. [Google Scholar] [CrossRef] [PubMed]
[25] Guo, S., Wu, H., Ji, J., Sun, Z., Xiang, B., Wu, W., et al. (2023) Association between Gut Microbial Diversity and Technique Failure in Peritoneal Dialysis Patients. Renal Failure, 45, Article ID: 2195014. [Google Scholar] [CrossRef] [PubMed]
[26] Fransen, F., van Beek, A.A., Borghuis, T., Meijer, B., Hugenholtz, F., van der Gaast-de Jongh, C., et al. (2017) The Impact of Gut Microbiota on Gender-Specific Differences in Immunity. Frontiers in Immunology, 8, Article No. 754. [Google Scholar] [CrossRef] [PubMed]
[27] Wang, J., Wu, S., Zhang, J., Li, Y., Wu, Y. and Qi, X. (2023) Correlation between Gut Microbiome and Cognitive Impairment in Patients Undergoing Peritoneal Dialysis. BMC Nephrology, 24, Article No. 360. [Google Scholar] [CrossRef] [PubMed]
[28] Martín-del-Campo, F., Vega-Magaña, N., Salazar-Félix, N., Cueto-Manzano, A., Peña-Rodríguez, M., Cortés-Sanabria, L., et al. (2024) Gut Microbiome Is Related to Cognitive Impairment in Peritoneal Dialysis Patients. Nutrients, 16, Article No. 2659. [Google Scholar] [CrossRef] [PubMed]
[29] Tian, N., Yan, Y., Chen, N., Xu, S., Chu, R., Wang, M., et al. (2023) Relationship between Gut Microbiota and Nutritional Status in Patients on Peritoneal Dialysis. Scientific Reports, 13, Article No. 1572. [Google Scholar] [CrossRef] [PubMed]
[30] Hu, J., Zhong, X., Yan, J., Zhou, D., Qin, D., Xiao, X., et al. (2020) High-Throughput Sequencing Analysis of Intestinal Flora Changes in ESRD and CKD Patients. BMC Nephrology, 21, Article No. 12. [Google Scholar] [CrossRef] [PubMed]
[31] March, D.S., Jones, A.W., Bishop, N.C. and Burton, J.O. (2020) The Efficacy of Prebiotic, Probiotic, and Synbiotic Supplementation in Modulating Gut-Derived Circulatory Particles Associated with Cardiovascular Disease in Individuals Receiving Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Renal Nutrition, 30, 347-359. [Google Scholar] [CrossRef] [PubMed]
[32] Tavares, L.M., de Jesus, L.C.L., Batista, V.L., Barroso, F.A.L., dos Santos Freitas, A., Campos, G.M., et al. (2023) Synergistic Synbiotic Containing Fructooligosaccharides and Lactobacillus delbrueckii CIDCA 133 Alleviates Chemotherapy-Induced Intestinal Mucositis in Mice. World Journal of Microbiology and Biotechnology, 39, Article No. 235. [Google Scholar] [CrossRef] [PubMed]
[33] Lin, W., Jiang, C., Yu, H., Wang, L., Li, J., Liu, X., et al. (2021) The Effects of Fushen Granule on the Composition and Function of the Gut Microbiota during Peritoneal Dialysis-Related Peritonitis. Phytomedicine, 86, Article ID: 153561. [Google Scholar] [CrossRef] [PubMed]

为你推荐